Compare SELF & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SELF | VNRX |
|---|---|---|
| Founded | 1983 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.8M | 38.2M |
| IPO Year | N/A | N/A |
| Metric | SELF | VNRX |
|---|---|---|
| Price | $5.06 | $0.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 55.5K | ★ 2.2M |
| Earning Date | 11-07-2025 | 11-13-2025 |
| Dividend Yield | ★ 5.69% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $12,733,279.00 | $1,472,007.00 |
| Revenue This Year | $1.59 | $55.98 |
| Revenue Next Year | $1.62 | $420.37 |
| P/E Ratio | $31.82 | ★ N/A |
| Revenue Growth | 3.36 | ★ 14.48 |
| 52 Week Low | $4.73 | $0.22 |
| 52 Week High | $5.89 | $0.94 |
| Indicator | SELF | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.11 | 45.05 |
| Support Level | $5.02 | $0.22 |
| Resistance Level | $5.19 | $0.26 |
| Average True Range (ATR) | 0.13 | 0.02 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 71.21 | 60.42 |
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.